ArticleOncogene2025

CBX2 as a therapeutic target in colorectal cancer: insights into the altered chromatin accessibility via RUNX1-CBX2-MAP4K1 axis.

Bangting Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.